Conference Coverage from
The Liver Meeting 2017: American Association for the Study of Liver Diseases (AASLD)
Progress in Fatty Liver and Pediatric Liver Disease
Damian McNamara
October 11, 2017
The Liver Meeting 2017: American Association for the Study of Liver Diseases (AASLD)
Progress in Fatty Liver and Pediatric Liver Disease
Damian McNamara
October 11, 2017
WASHINGTON, DC — Advances in the treatment of nonalcoholic steatohepatitis (NASH) — including results from a phase 2 trial of a liver-targeted selective inhibitor of acetyl-CoA carboxylase — will be in the spotlight here at The Liver Meeting 2017: American Association for the Study of Liver Diseases (AASLD).
Link
No comments:
Post a Comment